SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SonoSight (SONO), Handheld ultrasound for the masses
SONO 18.49-2.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ben Wa who wrote (185)8/17/1999 7:29:00 PM
From: Sam  Read Replies (1) of 365
 
Hold the Mayo,*
Here are a few doctors' comments on the product... Reprinted from a prior post from last year. Excerpts, in case you can't read more than one paragraph at a time: "As essential as a stethoscope in a few years, will improve the quality of medicine, lower the overal cost, improve a clinic's efficiency." You don't buy the story, great, short the stock. It's your WAG, and your money.

'Handheld ultrasound is a long held dream of many in the medical community,' said James B. Seward,
MD, Professor of Medicine and Pediatrics and Director of the Echocardiography Laboratory, Mayo
Clinic. 'Clinicians need a device that is small enough and affordable enough to extend general examination
capabilities right at the patient bedside. I believe that handheld ultrasound could become as essential as the
stethoscope in a few years.'

Steven R. Goldstein, MD, Professor of Obstetrics and Gynecology, New York University Medical
Center, who has worked with ATL on evaluating prototype designs said, 'I have believed in this concept
for ten years and am firmly convinced that some day medical students are going to look at us and say,
'You used to feel without looking? How did you know what your patients had?'

'The important aspect of this new tool is that it would allow you to formulate a diagnosis and a plan of
management in a much more efficient time frame, a distinct benefit to the patient,' explained Paul N.
Fuller, MD, MPH, FACOG, Chair of the Kaiser Permanente National Product Council. 'It has the
potential to improve the quality of medicine, lower the overall cost of providing care to that patient and
improve your clinic's efficiency.'

(*Actually, I'm a mustard guy myself, but I'm not shorting. I wish someone would, though, to get the price of the thing down a little.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext